Manisha Raja, Dermatology Account Manager at LEO Pharma and winner of the Secondary Care...

Congratulations on your Pf Award win Manisha, how did it feel when your name was announced? Thank you! My jaw dropped when my name was...

BD and iTS Leadership demonstrate how honesty and an appetite to solve problems can...

  Tracey Clarke HR Director for UK/Ireland and the Nordic region, BD, on how to create a no-blame culture of continuous learning.   What is BD? BD is a...

Amryt Pharma and University College Dublin unite to bring hope to ‘butterfly children’, who...

Novel gene therapy shows promise Amryt Pharma and University College Dublin unite to bring hope to ‘butterfly children’, who suffer from an incurable skin...

Consilient Health’s Ian Sampson on the importance of traditional sales skills in an evolving...

  More than ever, we are adopting new and innovative ways to communicate, and pharma is no different. Whilst traditional sales skills are just as...

eDetailing: Where are we in 2018?

Words by Dr Andrée Bates Detailing remains a core part of any pharmaceutical company’s sales approach and has become a large part of their promotional...

How can pharma harness the power of data to inform its scientific communications strategy?

Words by Simon Mason Navigating the fast-changing healthcare data landscape is becoming increasingly challenging for pharma, owing to issues such as the rapid growth of...

Foreseeable future: MSD’s focus on emerging talent

    Adelina Ismail Role: Graduate Brand and Customer Manager, Vaccines & Women’s Health Degree: BSc Marketing Management (Hons), Lancaster University 2-year graduate scheme: First year as a junior brand...

Gaining access: For products to commercially succeed it’s about what and who you know

Words by Andreas Knight   Many consider market access as a new component of commercial pharma, but in reality it has always been around in one...

2018: A pivotal year for outsourcing for Ashfield

Managing Director of Ashfield Commercial and Clinical UK, Colin Watson, talks about meeting changing industry demands, new innovations for a new year and why...

Latest articles

Phase III trial results of PT010 combination therapy in COPD

AstraZeneca has announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budesonide/...

Brands by numbers: Launch excellence in an increasingly specialised world

As the focus turns to specialist therapy areas and competition increases, achieving a successful launch is becoming even more challenging.

Pharmaceutical job opportunities: Star recruits for ground-breaking product launch

Star, the UK's first choice outsourcing and resourcing provider to the pharmaceutical, medical device and healthcare industries is delighted to announce a new partnership. Through...